NCT00732602已完成不适用
The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes
University Hospital, Gentofte, Copenhagen1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2008年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 8
- 试验地点
- 1
- 主要终点
- plasma-glucagon Area Under Curve at 0-90 min. and 90-180 min.
研究概览
简要总结
The purpose of this study is to determine whether Glucose-dependent Insulinotropic Polypeptide (GIP) or Glucagon Like Peptide 2 (GLP-2) has an affect on the secretion of Glucagon from the pancreas in patients with type 1 diabetes mellitus.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Caucasians over 18 years with type 1 diabetes (WHO criteria)
- •Arginine test without rise in plasma C-peptide
- •Normal blood Hemoglobin
- •Informed consent
排除标准
- •Liver disease
- •Diabetic nephropathy
- •Treatment with medications unpausable for 12 hours
结局指标
主要结局
plasma-glucagon Area Under Curve at 0-90 min. and 90-180 min.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?Diabetes MellitusNCT01048268University Hospital, Gentofte, Copenhagen30
已完成
不适用
Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid MetabolismHealthy SubjectsNCT00999271Hvidovre University Hospital30
Unknown
不适用
The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Human Adipose Tissue: An In Vivo StudyAdipose TissueNCT00809029Liverpool University Hospitals NHS Foundation Trust12
已完成
1 期
GIP: Glucose-dependent Insulinotropic PeptideType 2 DiabetesNCT00239707National Institute on Aging (NIA)41
已完成
不适用
Separate and Combined Extrapancreatic Effects of the Incretin HormonesHyperglycemia PancreatectomyNCT05177653University Hospital, Gentofte, Copenhagen13